Johnson & Johnson Services Inc acquires Halda Therapeutics
Johnson & Johnson Services Inc agreed to acquire Halda Therapeutics. Reported deal value: $3.05B. Status: Pending. Sector: Biotechnology. Target headquarters context: New Haven, Connecticut, United States.
This page summarizes publicly available information about the transaction as of 2026-01-08. Figures and status may change as filings and press coverage update.
Or on LinkedIn J&J Completes $3 - Bn Acquisition of Halda Therapeutics Johnson & Johnson has completed its $3 .05- billion acquisition of Halda Therapeutics , a clinical-stage bio/pharmaceutical company focused on oral therapies for multiple types of solid tumors, including prostate cancer
Deal timeline
This transaction is classified in Biotechnology with a reported deal value of $3.05B. Figures and status may change as sources update.